New drug aims to stop stomach bug before it starts
NCT ID NCT04182490
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This study tested an experimental drug called LMN-101 in 42 healthy adults to see if it could prevent or control Campylobacter infection, a common cause of food poisoning. Participants took LMN-101 or a placebo for two days, then were deliberately exposed to the bacteria. The main goal was to check safety and side effects. The study is complete, and results will show whether LMN-101 helps the body fight off the infection.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAMPYLOBACTER INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Pharmaron
Baltimore, Maryland, 21201, United States
Conditions
Explore the condition pages connected to this study.